The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Respiratory infections such as COVID-19 have been responsible for numerous pandemics and have placed a substantial burden on ...

A 4·6 billion-year-old patient of ill-defined sex is seen in the emergency room because of multiple, uncontrolled respiratory ...

Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle ...

"Could move into the plains across states." Scientists sound alarm over growing threat of drug-resistant respiratory ...

Respiratory tract diseases articles from across Nature Portfolio Respiratory tract diseases are illnesses that affect components of the respiratory system, including the nasal passages, the ...